← Back to all trials
Not Yet Recruiting
NCT07658937
Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients
Conditions: Health-Related Quality-of-Life, Cancer, Health Communication
Sex: All
Ages: 15 Years – 25 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Connecticut Children's Medical Center
Location: Children's Hospital Los Angeles Los Angeles California
Summary
The goal of this clinical trial is to learn if ReSPECT, which includes a pre-visit checklist for patients to complete and an informational website, can work well in practice to help adolescent and young adult oncology patients communicate with their clinicians about sexual and reproductive health (SRH). SRH includes topics such as how cancer may impact puberty and development, best methods for contraception during cancer treatment, fertility risk and fertility preservation strategies, and dating/relationships during and after cancer. The study will also help researchers better understand how to best measure the impact of ReSPECT on improving SRH communication for future testing of ReSPECT.
The main questions the study aims to answer are:
How well does ReSPECT work in practice? Do patients and clinicians like ReSPECT, and do they find it helpful? What are the best ways to test ReSPECT and measure whether it works?
Participants will:
Use ReSPECT to support a conversation about SRH during an outpatient oncology clinic appointment Complete surveys before and after using ReSPECT Provide feedback on their experience using ReSPECT in a short interview
Eligibility Criteria
Inclusion Criteria:
* Age 15-25 years old
* Has a cancer diagnosis
* ≥2 months from diagnosis/initiation of therapy, whichever occurred later
* Currently on cancer-directed therapy
* Speaks and reads English
* Approval from primary oncology team
* Study participation by primary oncology clinician
Exclusion Criteria:
* Not able to provide informed consent/assent
* Insufficient cognitive functioning to complete study measures, as determined by a member of the patient's primary oncology team
* Exceeds primary oncologist's participant limit (3 patients/clinician)
Source: ClinicalTrials.gov (NCT07658937). StuddyBuddy aggregates publicly available trial information.